Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 3/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17205375 | 1.00 | LPAR1 (0.45) | LPAR1LPAR3LPAR2CES1FAAH | |
| SCHEMBL21219356 | 0.95 | ALDH1A1 (0.46) | — | |
| SCHEMBL18770581 | 0.95 | ALDH1A1 (0.46) | — | |
| SCHEMBL18770582 | 0.95 | ALDH1A1 (0.46) | — | |
| SCHEMBL18770788 | 0.95 | ALDH1A1 (0.46) | — | |
| SCHEMBL20548037 | 0.95 | ALDH1A1 (0.46) | — | |
| SCHEMBL17366573 | 0.85 | LPAR1 (0.47) | LPAR1LPAR3LPAR2CES1FAAH | |
| SCHEMBL25762061 | 0.85 | LPAR1 (0.47) | LPAR1LPAR3LPAR2CES1FAAH | |
| SCHEMBL20580329 | 0.85 | ALDH1A1 (0.46) | — | |
| SCHEMBL29286069 | 0.82 | LPAR1 (0.45) | LPAR1LPAR3LPAR2CES1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3641810-A1 | HERPES SIMPLEX VIRUS VACCINE | Modernatx, Inc. (US) | 2020-04-29 | — | — | EP | disclosed |
| EP-3538146-A2 | INFLUENZA VACCINE | ModernaTX, Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| WO-2018200737-A1 | HERPES SIMPLEX VIRUS VACCINE | MODERNATX, INC. (US) | 2018-11-01 | — | — | WO | disclosed |
| WO-2018175783-A1 | RNA BACTERIAL VACCINES | MODERNATX, INC. (US) | 2018-09-27 | — | — | WO | disclosed |
| EP-3364982-A2 | SEXUALLY TRANSMITTED DISEASE VACCINES | ModernaTX, Inc. (US) | 2018-08-29 | — | — | EP | disclosed |
| EP-3364983-A2 | RESPIRATORY VIRUS VACCINES | ModernaTX, Inc. (US) | 2018-08-29 | — | — | EP | disclosed |
| EP-3365008-A1 | RESPIRATORY SYNCYTIAL VIRUS VACCINE | ModernaTX, Inc. (US) | 2018-08-29 | — | — | EP | disclosed |
| EP-3365007-A2 | BROAD SPECTRUM INFLUENZA VIRUS VACCINE | ModernaTX, Inc. (US) | 2018-08-29 | — | — | EP | disclosed |
| WO-2018089851-A2 | INFLUENZA VACCINE | MODERNATX, INC. (US) | 2018-05-17 | — | — | WO | disclosed |
| WO-2017070622-A1 | RESPIRATORY SYNCYTIAL VIRUS VACCINE | MODERNATX, INC. (US) | 2017-04-27 | — | — | WO | disclosed |
| WO-2017070616-A2 | SEXUALLY TRANSMITTED DISEASE VACCINES | MODERNATX, INC. (US) | 2017-04-27 | — | — | WO | disclosed |
| WO-2017070620-A2 | BROAD SPECTRUM INFLUENZA VIRUS VACCINE | MODERNATX, INC. (US) | 2017-04-27 | — | — | WO | disclosed |
| EP-3134131-A1 | NUCLEIC ACID VACCINES | ModernaTX, Inc. (US) | 2017-03-01 | — | — | EP | disclosed |
| WO-2015164674-A1 | NUCLEIC ACID VACCINES | MODERNA THERAPEUTICS, INC. (US) | 2015-10-29 | — | — | WO | disclosed |